Investing.com - Medtronic reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Medtronic announced earnings per share of $1.30 on revenue of $7.6B. Analysts polled by Investing.com EPS of $1.28 on revenue of $7.7B.
Medtronic 's are down 20% and is trading at $82.29 , still down 30.73% from its 52 week high of $118.80 set on Monday, November 22, 2021.
Medtronic follows other major Healthcare sector earnings this month
Medtronic's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on Friday, October 28, 2022 with third quarter EPS of $3.66 on revenue of $14.81B, for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar